Teva Pharmaceuticals (TEVA) ADR

Sell:$32.77Buy:$32.79Price increased$0.78 (2.44%)

Prices delayed by at least 15 minutes
Sell:$32.77
Buy:$32.79
Change:Price increased$0.78 (2.44%)
Deal now
Prices delayed by at least 15 minutes
Sell:$32.77
Buy:$32.79
Change:Price increased$0.78 (2.44%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Key people

Richard D. Francis
President, Chief Executive Officer, Director
Eliyahu Sharon Kalif
Chief Financial Officer, Executive Vice President
Placid Jover
Executive Vice President, Chief Human Resources Officer
Richard Daniell
Executive Vice President - European Commercial
Christine Fox
Executive Vice President - U.S. Commercial
Eric A. Hughes
Executive Vice President - Global R & D, Chief Medical Officer
Evan Lippman
Executive Vice President - Business Development
David R. McAvoy
Executive Vice President, Chief Legal Officer
Mark Sabag
Executive Vice President - International Markets Commercial
Matthew Shields
Executive Vice President - Teva Global Operations
Sol J. Barer
Independent Chairman of the Board
Rosemary A. Crane
Independent Director
Amir Elstein
Independent Director
Chen Lichtenstein
Independent Director
Gerald M. Lieberman
Independent Director
Click to see more

Key facts

  • Shares in issue
    1.25bn
  • EPIC
    TEVA
  • ISIN
    US8816242098
  • Location
    Israel
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $37.67bn
  • Employees
    37,000
  • Exchange
    New York Stock Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.